1. bookVolume 59 (2013): Issue 4 (December 2013)
Journal Details
License
Format
Journal
First Published
04 Apr 2014
Publication timeframe
4 times per year
Languages
English
access type Open Access

The effect of herbal materials on the p-glycoprotein activity and function

Published Online: 09 Apr 2014
Page range: 129 - 141
Journal Details
License
Format
Journal
First Published
04 Apr 2014
Publication timeframe
4 times per year
Languages
English

P-glycoprotein (P-gp) encoded by the MDR1 (multidrug resistance 1) gene is ATP-dependent transporting protein which is localizated in the cell membrane. P-gp is expressed mainly in organs with the secretory functions and its physiological role concerns tissue protection against xenobiotics. P-glycoprotein is involved in the permeability barriers of the blood-brain, blood-placenta directly protecting these organs. It participates in the transport of many drugs and other xenobiotics affecting their absorption, distribution, metabolism and excretion. The high P-gp activity in the cell membranes of cancer tissue is a major cause of lack of effectiveness of chemotherapy. Hence, the methods which could increase the sensibility of these pathological cells to cytostatics are still being searched. In the experimental studies it was shown that natural plant substances may have an effect on the expression level and activity of P-glycoprotein. Hypericum perforatum, Ginkgo biloba and Camellia sinensis increase P-gp activity while curcumin from Curcuma longa, piperine and silymarin inhibit this protein. Taking into account a wide substrate spectrum of P-gp, application of our knowledge on interactions of herbals and synthetic drugs should be considered in order to improve drug impact on different tissues.

Keywords

Słowa kluczowe

1. Loo TW, Bartlett MC, Clarke DM. Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. Biochem J 2006; 396:537-545.Search in Google Scholar

2. Loo TW, Bartlett MC, Clarke DM. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. Biochem J 2006; 399:351-359.Search in Google Scholar

3. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. ONC 2003; 22:7468-7485.Search in Google Scholar

4. Eichhorn T, Efferth T. P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol 2012; 141:557-570.Search in Google Scholar

5. Kozłowska-Rup D, Czekaj P. Barierowa rola białek nadrodziny ABC w łożysku ludzkim. Ginekol Pol 2011; 82:56-63.Search in Google Scholar

6. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77:491-502.Search in Google Scholar

7. Behravan J, Piquette-Miller M. Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol 2007; 3:819-830.Search in Google Scholar

8. Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008; 38:802-832.Search in Google Scholar

9. Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1998; 101:289-294.Search in Google Scholar

10. Del Poeta G, Venditti A, Aronica G, Stasi R, Cox MC, Buccisano F. P-glycoprotein expression in de novo acute myeloid leukemia. Leuk Lymphoma 1997; 27:257-274.Search in Google Scholar

11. Guerci A, Merlin JL, Missoum N, Feldmann L, Marchal S, Witz F et al. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simoultanously determined by flow cytometry. Blood J 1995; 85:2147-53.Search in Google Scholar

12. Liu YY, Han TY, Giuliano AE, Cabot MC. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 2001; 15:719-730.Search in Google Scholar

13. Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J Pharmacol Exp Ther 2001; 299:434-41.Search in Google Scholar

14. Droździk M, Białecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetic 2003; 13:259-263.Search in Google Scholar

15. Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003; 124:26-33.Search in Google Scholar

16. Jeziorna M, Klimowicz A, Bielecka-Grzela S. The influence of P-glycoprotein and certain cytochrome P-450 isoenzymes on antimycotic azoles. Post Dermatol Alergol 2009; 6:533-538.Search in Google Scholar

17. Roberts RL, Joyce PR, Mulder RT, Begg EJ, Kennedy MA. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics 2002; 2:191-196.Search in Google Scholar

18. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP et al. Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359:30-36.Search in Google Scholar

19. Rapposelli S, Digiacomo M, Balsamo A. P-gp transporter and its role in neurodegenerative diseases. Curr Top Med Chem 2009; 9:209-17.Search in Google Scholar

20. Sikic I. Modulation of multidrug resistance: at the threshold. J Clin Oncol 1993; 11:1629-1635.Search in Google Scholar

21. Kasper S, Gastpar M, Möller HJ, Müller WE, Volz HP, Dienel A et al. Better tolerability of St. John‘s wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. Int Clin Psychopharmacol 2010; 25:204-13.Search in Google Scholar

22. Linde K, Berner MM, Kriston L. St John’s wort for major depression. Coch Database Syst Rev 2008; 8:CD000448.Search in Google Scholar

23. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John’s wort, an herbal preparation used in treatment of depression. J Pharmacol Exp Ther 2000; 294:88-95.Search in Google Scholar

24. Bilia AR, Gallori S, Vincieri FF. St. John’s wort and depression: efficacy, safety and tolerability - an update. Life Sci 2002; 70:3077-96.Search in Google Scholar

25. Calapai G, Crupi A, Firenzuoli F et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum. Pharmacopsych 2001; 34:45-9.Search in Google Scholar

26. Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD. Effect of St John‘s wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 71:414-20.Search in Google Scholar

27. Rengelshausen J, Banfield M, Riedel KD, Burhenne J, Weiss J, Thomsen T et al. Opposite effects of short-term and long-term St John‘s wort intake on voriconazole pharmacokinetics. Clin Pharmacol Ther 2005; 78: 25-33.Search in Google Scholar

28. Dürr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ et al. St John‘s Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000; 68:598-604.Search in Google Scholar

29. Bauer S, Störmer E, Johne A, Krüger H, Budde K, Neumayer HH et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John‘s wort in renal transplant patients. Br J Clin Pharmacol 2003; 55:203-11.Search in Google Scholar

30. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM et al. St. John‘s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000; 97:7500-2.Search in Google Scholar

31. Suhaimi H, Ahmad FB, Friberg SE. Curcumin in a model skin lotion formulation. J Pharm Sci 1995; 84:376-80.Search in Google Scholar

32. Nagabhushan M, Bhide SV. Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutr Cancer 1986; 8:201-10.Search in Google Scholar

33. Limtrakul P, Anuchapreeda S, Lipigorngoson S, Dunn FW. Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer 2001; 1:1-7. Search in Google Scholar

34. Asai A, Miyazawa T. Dietary curcuminoids prevent high-fat diet induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 2001; 131:2932-5.Search in Google Scholar

35. Suryanarayana P, Krishnaswamy K, Reddy GB. Effect of curcumin on galactose-induced cataractogenesis in rats. Mol Vis 2003; 9:223-30.Search in Google Scholar

36. Tang XQ, Bi H, Feng JQ, Cao JG. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol Sin 2005; 26:1009-16.Search in Google Scholar

37. Pallis M, Russell N. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. Blood 2000; 95:2897-2904.Search in Google Scholar

38. Bajad S, Bedi KL, Singla AK et al. Antidiarrhoeal activity of piperine in mice. Planta Med 2001; 67:284-7.Search in Google Scholar

39. Lin Z, Hoult JR, Bennett DC et al. Stimulation of mouse melanocyte proliferation by Piper nigrum fruit extract and its main alkaloid, piperine. Planta Med 1999; 65:600-3.Search in Google Scholar

40. Zutshi RK, Singh R, Zutshi U et al. Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis. J Assoc Physicians India 1985; 33:223-4.Search in Google Scholar

41. Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991; 41:615-7.Search in Google Scholar

42. Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomed 2011; 19:83-7.Search in Google Scholar

43. Wu JW, Lin LC, Tsai TH. Drug-drug interactions of sylimarin on the perspective of pharmacokinetics. J Ethnopharmacol 2009; 121:185-93.Search in Google Scholar

44. Dixit N, Baboota S, Kohli K, Ahmad S, Ali J. Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol 2007; 39:172-9Search in Google Scholar

45. Zhang S, Morris ME. Effects of the flavonoids biochanin A and sylimarin on P-glycoprotein mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm Res 2003; 20:1184-91.Search in Google Scholar

46. Gurley BJ, Barone GW, Williams DK et al. Effect of milk thistle (Sylibum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2006; 34:69-74.Search in Google Scholar

47. Li L, Stanton JD, Tolson AH, Luo Y, Wang H. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 2009; 26:872-82.Search in Google Scholar

48. Yang CY, Chao PD, Hou YC et al. Marked decrease of cyclosporine bioavailability caused by coadministration of ginkgo and onion in rats. Food Chem Toxicol 2006; 44:1572-8.Search in Google Scholar

49. Wang E, Barecki-Roach M, Johnson WW. Elevation of P-glycoprotein function by a catechin in green tea. Biochem Biophys Res Commun 2002; 297:412-8.Search in Google Scholar

50. Lin HL, Liu TY, Lui WY, Chi CW. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. BJC 1999; 85:1937-1942.Search in Google Scholar

51. Li GH, Liu MX, Sun FJ, Wang N, Yin GP, Li XJ et al. The effect of tetrandrine on the expression of the P170, LRP and TOPO II in S180s tumor cell induced by chemotherapy in the mice with acquired multidrug resistance. Zhongguo Zhong Yao Za Zhi 2005; 30:1280-1282.Search in Google Scholar

52. Cao J, Chen X, Liang J, Yu XQ, Xu AL, Chan E et al. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra. DMD 2007; 35:539-553.Search in Google Scholar

53. Choi CH, Kang G, Min YD. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med 2003; 69:235-240.Search in Google Scholar

54. Gao N, Zhang Y, Mao JQ, Li GQ, Zhou W, Gao B et al. Effects of some traditional Chinese drugs on Mdr1 gene and its expression product in K562/A02 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16:785-789.Search in Google Scholar

55. Fong WF, Wang C, Zhu GY, Leung CH, Yang MS, Cheung HY. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. Phytomedicine 2007; 14: 160-165.Search in Google Scholar

56. Geng J, Zhou D. Coriaria lactone induces in vitro the overexpression of multidrug resistance P-glycoprotein in astrocyte from rat brain. Sichuan Da Xue Xue Bao Yi Xue Ban 2008; 39:80-83.Search in Google Scholar

57. Suzuki H, Tanabe H, Mizukami H, Inoue M. Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine. Biol Pharm Bull 2010; 33: 677-682. Search in Google Scholar

58. Qiu W, Jiang XH, Liu CX, Ju Y, Jin JX. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research 2009; 23: 1553-1558.Search in Google Scholar

59. Vaidyanathan JB, Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 2003; 307: 745-752.Search in Google Scholar

60. Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 2004; 56:1307-1314.Search in Google Scholar

61. Huang Y, Dong G, Hong X, Chai H, Yuan X. Studies on reversing MDR of K562/A02 by ramification of curcumin hydrolyzed. Zhongguo Zhong Yao Za Zhi 2010; 35: 2460-2463.Search in Google Scholar

62. Ampasavate C, Sotanaphun U, Phattanawasin P, Piyapolrungroj N. Effects of Curcuma spp. on P-glycoprotein function. Phytomedicine 2010; 17:506-512.Search in Google Scholar

63. Hu YJ, Shen XL, Lu HL, Zhang YH, Huang XA, Fu LC et al. Tenacigenin B derivatives reverse P-glycoproteinmediated multidrug resistance inHepG2/Dox cells. J Nat Prod 2008; 71:1049-1051.Search in Google Scholar

64. Dong Y, Zhang Y, Yang Q, Li Y, Zhu X. Absorption of extractive Radix Paeoniae Alba in rat everted gut sacs and its interaction with P-glycoprotein. Zhongguo Zhong Yao Za Zhi 2009; 34:884-888.Search in Google Scholar

65. Chan K, Liu ZQ, Jiang ZH, Zhou H, Wong YF, Xu HX et al. The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol 2006; 103: 425-432.Search in Google Scholar

66. Wu JY, Fong WF, Zhang JX, Leung CH, Kwong HL, Yang MS et al. Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani. Eur J Pharmacol 2003; 473: 9-17.Search in Google Scholar

67. Chen HY, Wu TS, Su SF, Kuo SC, Chao PD. Marked decrease of cyclosporin absorption caused by phellamurin in rats. Planta Med 2002; 68:138-141.Search in Google Scholar

68. Zhang R, Jie J, Zhou Y, Cao Z, Li W. Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo. Am J Chin Med 2009; 37: 657-667.Search in Google Scholar

69. Zhang J, Zhou F, Wu X, Gu Y, Ai H, Zheng Y et al. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions. Drug Metab Dispos 2010; 38: 2179-2187.Search in Google Scholar

70. Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB et al. Pseudolaric acid B, a novel microtubuledestabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin Cancer Res 2005; 11:6002-6011.Search in Google Scholar

71. Shen H, Xu W, Chen Q, Wu Z, Tang H, Wang F. Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription. J Cancer Research Clin Oncol 2010; 136: 659-665.Search in Google Scholar

72. Chen YW, Lin GJ, Chuang YP, Chia WT, Hueng DY, Lin CK et al. Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells. Anticancer Drugs 2010; 21: 502-513. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo